In humans, circulating FGF21 levels are elevated in metabolic syndrome, obesity, CVDs, diabetes, non-alcoholic fatty liver disease, mitochondrial myopathies, and cold exposure [26, 38, 62–69]. This evidence concerns the gene FGF21 and obesity due to melanocortin 4 receptor deficiency.